Osage University Partners (OUP)

🎙️ New Podcast Episode Alert: "Columbia Invents - Marc Singer and William Harrington" What does it take to turn groundbreaking university innovations into market-ready startups? With over $800M under management and a portfolio of 130+ investments in university startups, Marc Singer and William Harrington bring their expertise to the latest episode of Columbia Technology Ventures's podcast hosted by Orin Herskowitz Key topics covered in this episode: • The strategic importance of fundraising and building the right team • How to determine the perfect timing to spin out a university startup • Common pitfalls university entrepreneurs should avoid • Marc and Bill’s personal journeys into venture capital and their advice for aspiring VCs Whether you're a university founder, an innovation enthusiast, or someone curious about venture capital, this episode is packed with actionable insights you don’t want to miss. 🎧 Listen now ➡️ • Spotify: https://lnkd.in/eeVdYEq8 • Apple: https://lnkd.in/eTSYXwFd #VentureCapital #Entrepreneurship #UniversityStartups #Innovation #Fundraising

Applications for #Science2Startup are still open! Submit your #startup idea by the end of the day TODAY for an opportunity to present to top #biotech and #pharma execs, VCs and entrepreneurs. Apply now: https://lnkd.in/e7bPwMzX

We’ve extended our submission deadline for the 2025 #Science2Startup symposium on May 14th. This is your last chance to share your game-changing startup idea with leading #biotech and #pharma executives, VCs, and entrepreneurs – don’t wait, apply now! Applications are due by Dec 2 at midnight: https://lnkd.in/e7bPwMzX

Time is running out! #Science2Startup 2025, on Wednesday, May 14th, is a one-day symposium providing research applicants with a unique opportunity to receive guidance and mentorship from leaders in the biotech field. Submit your application by Friday, November 15th, to pitch your innovative startup ideas to leading #biotech and #pharma experts: https://lnkd.in/e7bPwMzX Don’t miss your chance to apply!

📢 Upcoming Webinar 🚨 Have you wondered what comprises a venture studio? How does this model differentiate from accelerators and incubators? Join us on Thursday, November 14th for an insightful webinar exploring the roles that venture studios play in the university innovation ecosystem. Jaimie Testai will be joined by: 🗣 Prutha Atre of Rose Rock Bridge 🗣 Taylor Bench of Summit Venture Studio 🗣 Tom Denison of SmartHealth Catalyzer, Inc. In addition to discussing the venture studio model, the panel will delve into their individual programs including how they interact with university technologies or startups. Register here: https://lnkd.in/e94hpt22 ➡ Be sure to submit any questions you have for our panelists when you register.

Join host firms F-Prime Capital, Atlas Venture, 5AM Ventures, Osage University Partners (OUP), and RA Capital Management, for the 2025 #Science2Startup symposium! This year's event is set for Wednesday, May 14th, featuring top scientists presenting to an audience of leading #biotech and #pharma executives, VCs, and entrepreneurs.   Have a groundbreaking idea for a biotech #startup? Submit your application by Friday, November 15th: https://lnkd.in/e7bPwMzX

Last week, we had the honor of having James C. Wu of First Round Capital and Jordan Windmueller of A* Capital join OUP's Ajay R. to discuss the AI Landscape and their insights as investors. Listen here to hear what they had to say: https://lnkd.in/ddvpFY4a

Last week, we hosted our 5th annual Ask a VC webinar. Osage University Partners (OUP) managing partners, Marc Singer and William Harrington answered anything and everything as it pertains to venture capital operations, decision-making, and the current investing environment. Watch their recording to hear what they had to say: https://lnkd.in/e5qyTJ4b

Join us TOMORROW! Ajay R., James C. Wu, & Jordan Windmueller are excited to share their insights on the AI Landscape!

Join us TOMORROW! Marc Singer and William Harrington will be answering your questions about VC operations, decision-making, and the current investing landscape.